UB Paderborn / Katalog / Suche / in CDI

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Canadian Medical Association journal (CMAJ), 2013-03, Vol.185 (4), p.309

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation

PloS one, 2011-11, Vol.6 (11), p.e27808

2011

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Challenges With Statin Therapy

Journal of the American Heart Association, 2016-01, Vol.5 (1), p.n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-04, Vol.303 (16), p.1603

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care

Circulation. Cardiovascular genetics, 2013-08, Vol.6 (4), p.400

2013

Link zum Volltext

Verfügbarkeit prüfen

Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1

Drug metabolism and disposition, 2019-08, Vol.47 (8), p.832-842

2019

Link zum Volltext

Verfügbarkeit prüfen

Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care

Canadian journal of cardiology, 2017-08, Vol.33 (8), p.1036-1043

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides

Clinical pharmacology and therapeutics, 2005-03, Vol.77 (3), p.170-177

2005

Link zum Volltext

Verfügbarkeit prüfen

Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic study

BMJ open, 2023-02, Vol.13 (2), p.e057151-e057151

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care

Journal of thrombosis and thrombolysis, 2020-02, Vol.49 (2), p.294-303

2020

Link zum Volltext

Verfügbarkeit prüfen

Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation

Journal of the American Geriatrics Society (JAGS), 2019-09, Vol.67 (9), p.1902-1906

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy

Blood, 2011-09, Vol.118 (11), p.3163-3171

2011

Link zum Volltext

Verfügbarkeit prüfen

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

Clinical pharmacology and therapeutics, 2003-01, Vol.73 (1), p.41-50

2003

Link zum Volltext

Verfügbarkeit prüfen

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

Clinical pharmacology and therapeutics, 2002-01, Vol.71 (1), p.11-20

2002

Link zum Volltext

Verfügbarkeit prüfen

Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine

American journal of hypertension, 2016-12, Vol.29 (12), p.1386-1393

2016

Link zum Volltext

Verfügbarkeit prüfen

The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study

Multiple sclerosis and related disorders, 2020-10, Vol.45, p.102401-102401, Article 102401

2020

Link zum Volltext

Verfügbarkeit prüfen

Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

The journal of clinical hypertension (Greenwich, Conn.), 2022-07, Vol.24 (7), p.804-813

2022

Link zum Volltext

Verfügbarkeit prüfen

Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

BMJ open, 2020-03, Vol.10 (3), p.e034086

2020

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Pharmacogenetics and genomics, 2008-05, Vol.18 (5), p.439-448

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of functionally variant MDR1 alleles among European Americans and African Americans

Clinical pharmacology and therapeutics, 2001-08, Vol.70 (2), p.189-199

2001

Link zum Volltext

Verfügbarkeit prüfen

Interactions between grapefruit juice and cardiovascular drugs

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004, Vol.4 (5), p.281-297

2004

Link zum Volltext

Verfügbarkeit prüfen

Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects

Basic & clinical pharmacology & toxicology, 2016-04, Vol.118 (4), p.284-291

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

Clinical pharmacokinetics, 2000, Vol.38 (1), p.41-57

2000

Link zum Volltext

Verfügbarkeit prüfen

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice

Clinical pharmacology and therapeutics, 2003-06, Vol.73 (6), p.529-537

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation

Overcoming Challenges With Statin Therapy

Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial

Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care

Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery

Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1

Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care

Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides

Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic study

Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care

Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine

The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study

Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe

Identification of functionally variant MDR1 alleles among European Americans and African Americans

Interactions between grapefruit juice and cardiovascular drugs

Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice

Suchergebnisse filtern